In the first in a three-part series, the Pioneer Press delves into payments that pharmaceutical companies make to Minnesota doctors. The paper reports such payments have fallen significantly because of financial pressures, the rising costs of developing new drugs, and more difficulty in finding doctors who will accept the fees. And, starting next year, drug companies and device makers will have to share data on such fees with the federal government.
Drug used to treat childhood leukemia in short supply
A doctor says when methotrexate is given to childhood leukemia patients its cure rate is 90 percent or better. But a shortage of the drug has patients and their families worried. U.S. Senator Amy Klobuchar is among those pressuring pharmaceutical companies to increase the supply.